| NBRIX | VGSLX | NBRIX / VGSLX | |
| Total Expense Ratio | 0.85 | 0.13 | 654% |
| Annual Report Gross Expense Ratio | 1.03 | 0.13 | 792% |
| Fund Existence | 18 years | 24 years | - |
| Gain YTD | -2.257 | 2.590 | -87% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 627M | 65.4B | 1% |
| Annual Yield % from dividends | 2.17 | 3.86 | 56% |
| Returns for 1 year | -2.81 | 2.17 | -130% |
| Returns for 3 years | 14.73 | 19.92 | 74% |
| Returns for 5 years | 6.66 | 26.29 | 25% |
| Returns for 10 years | 16.79 | 56.77 | 30% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBB | 173.25 | 1.15 | +0.67% |
| iShares Biotechnology ETF | |||
| ONOF | 38.43 | 0.12 | +0.31% |
| Global X Adaptive US Risk Management ETF | |||
| SEIE | 32.71 | 0.04 | +0.12% |
| SEI Select International Equity ETF | |||
| IDVO | 38.83 | 0.03 | +0.08% |
| Amplify CWP International Enh Div IncETF | |||
| BRF | 15.73 | -0.17 | -1.07% |
| VanEck Brazil Small-Cap ETF | |||